miRNAs as Therapeutic Tools and Biomarkers for Prostate Cancer
Prostate cancer (PCa) is the fifth cause of tumor-related deaths in man worldwide. Despite the considerable improvement in the clinical management of PCa, several limitations emerged both in the screening for early diagnosis and in the medical treatment. The use of prostate-specific antigen (PSA)-ba...
Saved in:
Main Authors: | Noemi Arrighetti (Author), Giovanni Luca Beretta (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
miRNAs as Biomarkers and Possible Therapeutic Strategies in Synovial Sarcoma
by: Shaowei Jiang, et al.
Published: (2022) -
Dietary stilbenes as modulators of specific miRNAs in prostate cancer
by: Anait S. Levenson
Published: (2022) -
The Ins and Outs of miRNAs as Biomarkers
Published: (2023) -
Small Extracellular Vesicles' miRNAs: Biomarkers and Therapeutics for Neurodegenerative Diseases
by: Wei Qing Lim, et al.
Published: (2023) -
A review on miRNAs as new biomarkers for colorectal cancer
by: Kiyanoush Mohammadi, et al.
Published: (2019)